✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Anecortave is an investigational drug.
There have been 33 clinical trials for Anecortave. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2003.
The most common disease conditions in clinical trials are Macular Degeneration, Glaucoma, and Glaucoma, Open-Angle. The leading clinical trial sponsors are Alcon Research, Manhattan Eye, Ear & Throat Hospital, and Federal University of São Paulo.
Recent Clinical Trials for Anecortave
|Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients||Cornea Research Foundation of America||N/A|
|A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension||Alcon Research||Phase 2|
|Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension||Alcon Research||Phase 2/Phase 3|